ARX vs AYA

ASX Healthcare sector comparison — updated 25 Mar 2026 — Healthcare sector

ARX

AROA BIO FPO [ARX]

51MEDIUM

AYA

ARTRYA FPO [AYA]

51MEDIUM

Score Breakdown

ARX AYA
Technical
41
65
Catalyst
53
50
Sentiment
50
50
Fundamental
78
82
Momentum
69
72
Risk Gate
47
50

Key Metrics

ARX Metric AYA
$201.1MMarket Cap$478.6M
58KAvg Volume (20d)437K
+0.1%Short Interest+0.7%
$0.80052-Week High$5.240
$0.35052-Week Low$0.560
-2.6%Daily Change+14.1%
$0.565Entry Price$3.080
-2.0%ROE-37.9%
-2.0%Profit MarginN/A

Active Signals

ARX Signals

RSI drifting toward oversold territory — worth watching
Trading below both moving averages — the trend is working against this one
Above-average volume (1.5x) on a red day — sellers in control
Below the 200-day average — the long-term trend is still working against it
Cash positive / operating cashflow positive
Low P/S ratio (2.2x)
Moderate revenue growth (+15%)
CANSLIM I: Institutional ownership (30%)

AYA Signals

On a tear — up 10.8% over the last 5 days
Trading above the 200-day average — the long-term trend is on your side
Strong cash runway (15 quarters)
Very high P/S ratio (16504.5x)
Moderate revenue growth (+8%)
EPS estimates revised upward (+10pts)
CANSLIM I: Institutional ownership (33%)
Not enough chatter to gauge sentiment — defaulting to neutral

Ask Scout AI to compare ARX and AYA in depth.

Open Scout AI →

Track both stocks and 2,200+ more — Free

Daily AI-powered screening across every ASX small cap.

Open Screener
ARX Full Analysis → AYA Full Analysis → Healthcare Sector →
GENERAL INFORMATION ONLY. SmallCapData provides algorithmic screening data and does not constitute personal financial advice, a recommendation, or an offer to buy or sell any security. This content is produced by an algorithm, not a licensed financial adviser. You should consider seeking independent financial advice before making any investment decision. Past performance is not indicative of future results. Trading in small-cap securities carries a high degree of risk, including the risk of total loss of capital. The author may hold positions in mentioned securities. SmallCapData does not hold an Australian Financial Services Licence (AFSL).